China approved Merck & Co.’s COVID-19 antiviral molnupiravir for emergency use as Beijing seeks to expand access to treatments amid a massive wave of infections following its abrupt pivot away from COVID-Zero in early December, reports Bloomberg. The drug, known by the brand name Lagevrio, has been granted conditional emergency approval for treating mild and […]
Category: Health Care
Japanese drugmaker Shionogi announced a partnership with a Chinese counterpart on Thursday to promote its oral COVID-19 treatment in China, as the country grapples with a surging outbreak, reports Nikkei Asia. The licensing agreement with Chia Tai Tianqing Pharmaceutical Group will let the Chinese company market the drug, known as Xocova, to medical institutions and pharmacies if […]
Chinese regulators and state-owned banks are taking steps to split staff at their workplaces in Beijing, sources told Reuters, as businesses brace for a possible spike in COVID cases after China relaxed virus restrictions in a major policy shift, reports Reuters. The arrangements highlight how lingering anxieties created by Beijing’s three-year ‘zero-COVID’ policy are likely […]
Categories
Release?
And then, suddenly, after months, no, in fact years, of insisting that the policy of dynamic zero was the great, glorious and correct policy and the proof that the China system was superior… the policy changed. Right now, the situation is still confused and testing for the virus is still an important part of life […]
Categories
China loosens COVID policies
China has announced wide-ranging relaxations to President Xi Jinping’s contentious zero-COVID restrictions, including for the first time home quarantine, as further evidence emerged of the economic damage from the pandemic controls, reports the Financial Times. The new measures, outlined on Wednesday by the State Council, China’s cabinet, were foreshadowed by a meeting of the Chinese Communist […]